Clinical Trial Update: Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

View source ↗

Summary

This clinical trial update describes a study exploring determinants of malignant hypertension onset and related target organ damages through the HAMA Biobank; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Hypertension

Snippet

Sponsor: Centre Hospitalier de PAU | Conditions: Malignant Hypertension | Status: NOT_YET_RECRUITING